首页> 外文OA文献 >>Patient preferences for glucagon-like peptide-1 receptorndash;agonist treatment attributes

【2h】

>Patient preferences for glucagon-like peptide-1 receptorndash;agonist treatment attributes

机译：>胰高血糖素肽-1受体 - 激动剂治疗属性的患者偏好

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Vivian T Thieu; Susan Robinson; Tessa Kennedy-Martin; Kristina S Boye; Luis-Emilio Garcia-Perez;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Patient preferences for glucagon-like peptide-1 receptor–agonist treatment attributes [J] . Vivian T Thieu, Susan Robinson, Tessa Kennedy-Martin, Patient Preference and Adherence . 2019,第2期

机译：患者对胰高血糖素样肽1受体激动剂治疗的偏爱
2. Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Na?ve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study [J] . Lei Qin, Stephanie Chen, Emuella Flood, Diabetes therapy . 2017,第2期

机译：胰高血糖素样肽1受体激动剂的治疗属性对初次注射的2型糖尿病初治患者很重要：一项跨国研究
3. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom [J] . Lei Qin, Stephanie Chen, Emuella Flood, Diabetes therapy . 2017,第2期

机译：胰高血糖素样肽1受体激动剂治疗属性对有注射经验的2型糖尿病患者很重要：在德国和英国的偏好研究
4. Novel Application of SCIEX 6600 TripleTOF Mass Spectrometer for Quantitative Assessment of Glucagon-Like Peptide-1 (GLP-1) Analog Pharmacokinetic Studies [C] . Yue Huang, Sarah Will, Anish Konkar, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：SCIEX 6600三重型质谱仪用于定量评估胰高血糖素肽-1（GLP-1）模拟药代动力学研究的新型施用
5. Combinatorial targeting of the glucagon-like peptide-1 and sulfonylurea-1 receptors using a complimentary mulitvalent glucagon-like peptide-1/glibenclamide ligand for the improvement of beta-cell targeting agents and diabetic treatment. [D] . Hart, Nathaniel. 2013

机译：使用互补的多价胰高血糖素样肽-1 /格列苯脲酰胺配体对胰高血糖素样肽-1和磺酰脲-1受体进行联合靶向，以改善β细胞靶向剂和糖尿病治疗。
6. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom [O] . Lei Qin, Stephanie Chen, Emuella Flood, 2017

机译：胰高血糖素样肽1受体激动剂的治疗属性对有注射经验的2型糖尿病患者很重要：在德国和英国的偏好研究
7. Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom [O] . 2017

机译：胰高血糖素样肽1受体激动剂的治疗属性对有注射经验的2型糖尿病患者很重要：在德国和英国的偏好研究

>Patient preferences for glucagon-like peptide-1 receptorndash;agonist treatment attributes

著录项

引文网络

相似文献

相关主题

期刊订阅